Total submissions: 2
| Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
|---|---|---|---|---|---|---|---|---|
| Clinical Genetics Laboratory, |
RCV004698088 | SCV005198243 | likely pathogenic | not provided | 2023-10-12 | criteria provided, single submitter | clinical testing | |
| Labcorp Genetics |
RCV004698088 | SCV005758144 | uncertain significance | not provided | 2024-07-04 | criteria provided, single submitter | clinical testing | This sequence change replaces histidine, which is basic and polar, with tyrosine, which is neutral and polar, at codon 635 of the SKIV2L protein (p.His635Tyr). This variant is present in population databases (rs772419565, gnomAD 0.004%). This variant has not been reported in the literature in individuals affected with SKIV2L-related conditions. An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |